LeukemiaPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia, Radiation-InducedLeukemia, LymphoidNevadaLeukemia, Lymphocytic, Chronic, B-CellLeukemia, ExperimentalElectromagnetic FieldsPaternal ExposureLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEnvironmental ExposurePesticidesLeukemia Virus, MurinePrecursor B-Cell Lymphoblastic Leukemia-LymphomaPreleukemiaInfant, NewbornCase-Control StudiesOmanLeukemia, T-CellLeukemia, Monocytic, AcuteCaliforniaMoloney murine leukemia virusCore Binding Factor Alpha 2 SubunitAsparaginaseSurvivorsLeukemia, Hairy CellLeukemia, B-CellLeukemia L1210Risk FactorsLeukemia Virus, BovineLeukemia Virus, FelineMaternal ExposureIcelandRegistriesRadio WavesGene Expression Regulation, LeukemicAntineoplastic AgentsAcute DiseaseMyeloid-Lymphoid Leukemia ProteinIncidencePrenatal Exposure Delayed EffectsMethotrexateNeoplasms, Radiation-InducedCranial IrradiationLeukemia P388FathersLeukemia, Biphenotypic, AcuteFriend murine leukemia virusOdds RatioHousingLeukemia-Lymphoma, Adult T-CellCytarabineHL-60 CellsPregnancyPrognosisParentsLeukemia, Megakaryoblastic, AcuteMothersRemission InductionAKR murine leukemia virusAntineoplastic Combined Chemotherapy ProtocolsFusion Proteins, bcr-ablBone MarrowLeukemia, Myeloid, Chronic-PhaseAntimetabolites, AntineoplasticOccupational ExposureInfectionRisk AssessmentBirth WeightAge FactorsDaunorubicinKaryotypingBreast FeedingRiskTumor Cells, CulturedLeukemia, Plasma CellLeukemia, Myeloid, Accelerated PhaseK562 CellsConfidence IntervalsOncogene Proteins, FusionLeukemia, Prolymphocytic, T-CellLogistic ModelsCell LineHuman T-lymphotropic virus 1Neoplasm ProteinsLeukemia, Myelomonocytic, JuvenileLeukemia, ProlymphocyticEnvironmental PollutantsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaLeukemic InfiltrationBase SequenceLymphomaMolecular Sequence DataChromosome Aberrationsfms-Like Tyrosine Kinase 3Leukemia, Basophilic, AcutePhiladelphia ChromosomeGenotypeTreatment Outcome